GE HealthCare Technologies Inc. reported a total revenue of $5.295 billion for the second quarter of 2026, marking a 5.7% increase from $5.007 billion in the same period last year. The company's net income attributable to GE HealthCare rose to $561 million, up 15.5% from $486 million in the prior year. For the first half of 2026, total revenues reached $10.425 billion, a 6.6% increase compared to $9.784 billion in the first half of 2025, while net income for the period was $950 million, down from $1.049 billion.

The company experienced significant growth in its Advanced Imaging Solutions (AIS) segment, which reported revenues of $3.771 billion, a 7.9% increase year-over-year. This growth was driven by strong performance in product lines such as CardioVascular & Interventional Solutions and Computed Tomography, as well as the acquisition of Intelerad. The Pharmaceutical Diagnostics (PDx) segment also saw a notable increase, with revenues rising 15.6% to $843 million, primarily due to higher volumes and prices in contrast media and radiopharmaceutical products. However, the Patient Care Solutions (PCS) segment faced challenges, with revenues declining 13.3% to $675 million, attributed to operational and fulfillment issues.

In terms of operational metrics, GE HealthCare's cash, cash equivalents, and restricted cash decreased to $2.105 billion as of June 30, 2026, down from $4.512 billion at the end of 2025. The company reported a total employee headcount of 48,000, reflecting ongoing adjustments in its workforce. The company also made strategic changes to its executive leadership and organizational structure, combining its Imaging and Advanced Visualization Solutions businesses into the new AIS segment.

Looking ahead, GE HealthCare anticipates continued revenue growth driven by its strategic investments in cloud, edge computing, and artificial intelligence technologies. However, the company remains cautious about potential impacts from global geopolitical tensions, supply chain disruptions, and ongoing tariff implications, which have already affected its operating income. The company plans to continue pursuing tariff refunds and managing costs to mitigate these challenges.

About GE HealthCare Technologies Inc.

GE Healthcare Technologies Inc. is a global provider of medical imaging, diagnostic, and patient monitoring equipment, along with digital and AI-enabled healthcare solutions. Its core segments include Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Serving healthcare providers worldwide, the company focuses on precision medicine, clinical decision support, and improving patient outcomes through innovative technology, comprehensive services, and a broad product portfolio.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov